REQUEST A DEMO
Total
USD $0.00
Search more companies

Hari Medi Pharma Private Limited (India)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Hari Medi Pharma Private Limited Profile Updated: December 20, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Hari Medi Pharma Private Limited is an unlisted company, incorporated on 04/07/2006. It has its registered office in the State of Rajasthan, India. Company's corporate identification number (CIN) is U24232RJ2006PTC022740 and registration number is 022740. The company is a manufacturing company, it is engaged in chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Legal Address
S-6, Geeeta Bhawan
Sriganganagar ; Rajasthan; Postal Code: 335001

Contact Details: Purchase the Hari Medi Pharma Private Limited report to view the information.

Basic Information
Outstanding Shares:
Purchase the Hari Medi Pharma Private Limited report to view the information.
Registered Capital:
Purchase the Hari Medi Pharma Private Limited report to view the information.
Incorporation Date:
July 04, 2006
Key Executives
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Whole Time Director
Purchase this report to view the information.
Managing Director
Company Performance
Financial values in the chart are available after Hari Medi Pharma Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
6.3%
Total operating revenue
6.63%
Operating profit (EBIT)
104.52%
EBITDA
95.13%
Net Profit (Loss) for the Period
96.76%
Total assets
5.51%
Total equity
13.4%
Operating Profit Margin (ROS)
2.46%
Net Profit Margin
1.72%
Return on Equity (ROE)
5.01%
Debt to Equity Ratio
0.96%
Quick Ratio
0.3%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?